|
1
|
Gao J and Zhang JB: Cancer invasion and
metastasis: basic and clinical aspects. Beijing Science Press;
Beijing: pp. 254–263. 2003
|
|
2
|
Wang X, Zhu Y, Ma Y, et al: The role of
cancer stem cells in cancer metastasis: New perspective and
progress. Cancer Epidemiol. 37:60–63. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Umemura S, Tsubouchi K, Yoshioka H, et al:
Clinical outcome in patients with leptomeningeal metastasis from
non-small cell lung cancer: Okayama Lung Cancer Study Group. Lung
Cancer. 77:134–139. 2012. View Article : Google Scholar
|
|
4
|
Xu Z: New concept and new way of treatment
of cancer metastasis. People’s Military Medical Press; Beijing: pp.
26–29. 2006
|
|
5
|
Gerl R and Vaux DL: Apoptosis in the
development and treatment of cancer. Carcinogenesis. 26:263–270.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang LX, Zhang X and Li J: Diagnosis and
treatment of prothrombotic state in patients with malignant tumors.
J Pract Oncol. 26:440–442. 2011.
|
|
7
|
Li XY, Xu L and Tan H: Anticoagulant and
thrombolytic treatment. Science and Technology Literature
Publishing House; Beijing: pp. 3102011
|
|
8
|
Wang CY, Yang F, Li GF, et al: Incidence
and clinical features of malignant venous thromboembolism: an
analysis of 862 cases. Acta Academiae Medicinae Militaris Tertiae.
32:2256–2257. 2010.
|
|
9
|
Khorana AA, Francis CW, Culakova E, et al:
Thromboembolism in hospitalized neutropenic cancer patients. J Clin
Oncol. 24:484–490. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Heit JA: Cancer and venous
thromboembolism: scope of the problem. Cancer Control. 12(Suppl 1):
S5–S10. 2005.
|
|
11
|
Zhang ZG, Han L and Zhao LB: Malignancies
and thromboembolic disease. J Pract Oncol. 25:346–347. 2010.
|
|
12
|
Hu L, Yang H, Su L, et al: Clinical
research of the hypercoagulable state in 180 patients with
malignant tumor. Med Res Ed. 27:30–32. 2010.
|
|
13
|
Cheng LZ and Ge HL: Clinical efficacy of
Huisheng Oral Solution as an auxiliary treatment for lung cancer.
Chin J Prim Med Pharm. 12:1580–1582. 2005.
|
|
14
|
Li HT, Fu GQ and Wang CQ: Clinical
observation of treating PHC by combining TACE with Huisheng oral
liquid. West China Med J. 18:516–517. 2003.
|
|
15
|
Xiong G, Zhou J, Hu YQ, et al: Huisheng
Oral Solution improves quality of life of patients with advanced
malignant tumors during chemotherapy. Shandong Med J. 51:57–58.
2011.
|
|
16
|
Fu J: Huisheng Oral Solution: pharmacology
and clinical applications. Shandong Med J. 51:110–111. 2011.
|
|
17
|
Johnson LN, Winter KM, Reid S, et al:
Cryopreservation of buffy-coat-derived platelet concentrates in
dimethyl sulfoxide and platelet additive solution. Cryobiology.
62:100–106. 2011.
Mathew M, Schilling T and Oettel M:
Connectivity percolation in suspensions of hard platelets. Phys Rev
E Stat Nonlin Soft Matter Phys. 85:0614072012.
|
|
18
|
Gao J: Invadation and metastases of
cancer. Union Press of Beijing Medical University and Peking Union
Medical College; Beijing: pp. 621996
|
|
19
|
Das UN: Essential fatty acids and their
metabolites as modulators of stem cell biology with reference to
inflammation, cancer, and metastasis. Cancer Metastasis Rev.
30:311–324. 2011. View Article : Google Scholar
|
|
20
|
Debaugnies F, Azerad MA, Noubouossié D, et
al: Evaluation of the procoagulant activity in the plasma of cancer
patients using a thrombin generation assay. Thromb Res.
126:531–535. 2010. View Article : Google Scholar
|
|
21
|
Kröger K, Weiland D, Ose C, et al: Risk
factors for venous thromboembolic events in cancer patients. Ann
Oncol. 17:297–303. 2006.PubMed/NCBI
|
|
22
|
Anderson JA and Weitz JI: Hypercoagulable
states. Clin Chest Med. 31:659–673. 2010. View Article : Google Scholar
|
|
23
|
De Cicco M: The prothrombotic state in
cancer: pathogenic mechanisms. Crit Rev Oncol Hematol. 50:187–196.
2004.PubMed/NCBI
|
|
24
|
Xiao B, Ma LL, Zhang SD, et al:
Correlation between coagulation function, tumor stage and
metastasis in patients with renal cell carcinoma: a retrospective
study. Chin Med J (Engl). 124:1205–1208. 2011.
|
|
25
|
Xue Y, Religa P, Cao RH, et al: Anti-VEGF
agents confer survival advantages to tumor-bearing mice by
improving cancer-associated systemic syndrome. Proc Natl Acad Sci
USA. 105:18513–18518. 2008. View Article : Google Scholar
|
|
26
|
Kepner N and Lipton A: A mitogenic factor
for transformed fibroblasts from human platelets. Cancer Res.
41:430–432. 1981.PubMed/NCBI
|
|
27
|
Möhle R, Green D, Moore MA, et al:
Constitutive production and thrombin-induced release of vascular
endothelial growth factor by human megakaryocytes and platelets.
Proc Natl Acad Sci USA. 94:663–668. 1997.PubMed/NCBI
|
|
28
|
Ahmad SA, Liu W, Jung YD, et al: The
effects of angiopoietin-1 and -2 on tumor growth and angiogenesis
in human colon cancer. Cancer Res. 61:1255–1259. 2001.
|
|
29
|
Zhu XY, Zhang XZ and Zhong XY: Effect of
shenqi fuzheng injection for hemopoietic and immune function
reconstruction in patients with hematologic malignancies undergoing
chemotherapy. Zhongguo Zhong Xi Yi Jie He Za Zhi. 30:205–206.
2010.(In Chinese).
|
|
30
|
Quan D, Gallinger S, Nhan C, et al: The
role of liver resection for colorectal cancer metastases in an era
of multimodality treatment: a systematic review. Surgery.
151:860–870. 2012. View Article : Google Scholar
|
|
31
|
Iwasaki A, Hamanaka W, Harnada T, et al:
Significance of platelet counts in patients who underwent surgical
treatment for lung metastasis. Int Surg. 92:103–109.
2007.PubMed/NCBI
|
|
32
|
Qu YZ, Guan JZ, Pan H and Song Y: Effects
of the Aidi Dripping Pills on immune functions of the tumor-bearing
mouse. J Tradit Chin Med. 30:122–125. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li JH, Chen CF, Li WW, et al: Effects of
Ethanol Extract of POLLEN TYPHAE on Immune Function in C57BL/6
Tumor Bearing Mice. Medicinal Plant. 2:12–14. 2011.
|
|
34
|
Huang GJ, Wang XM, Mao XY and Du ZT: An
experimental study of antitumor effects of Huisheng Oral Solution.
Chin Trad Patent Med. 20:37–39. 1998.
|
